SANUWAVE Health, Inc. (SNWV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 5M 10M 15M Q3 '21: 3.7M Q4 '21: 4.3M Q1 '22: 3.2M Q2 '22: 3.9M Q3 '22: 4.2M Q4 '22: 5.5M Q1 '23: 3.8M Q2 '23: 4.7M Q3 '23: 5M Q4 '23: 7M Q1 '24: 5.8M Q2 '24: 7.2M Q3 '24: 9.4M Q4 '24: 10.3M Q1 '25: 9.3M Q2 '25: 10.1M Q3 '25: 11.5M Q4 '25: 13.4M Q1 '26: 9.6M Q2 '26: 9.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 3.5M 7M 10.5M Q3 '21: 2.2M Q4 '21: 2.9M Q1 '22: 2.3M Q2 '22: 2.8M Q3 '22: 3M Q4 '22: 4.3M Q1 '23: 2.5M Q2 '23: 3.5M Q3 '23: 3.5M Q4 '23: 4.8M Q1 '24: 4.2M Q2 '24: 5.2M Q3 '24: 7.1M Q4 '24: 8M Q1 '25: 7.4M Q2 '25: 7.8M Q3 '25: 8.9M Q4 '25: 10M Q1 '26: 7.4M Q2 '26: 7.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -3.3M Q4 '21: -2.4M Q1 '22: -2M Q2 '22: -3M Q3 '22: -2.5M Q4 '22: -1.5M Q1 '23: -2M Q2 '23: 931K Q3 '23: -531K Q4 '23: 1M Q1 '24: -1.1M Q2 '24: 2M Q3 '24: 2M Q4 '24: 2M Q1 '25: 601K Q2 '25: 1.4M Q3 '25: 1.5M Q4 '25: 2M Q1 '26: -1.1M Q2 '26: -280K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-27M -18M -9M 0 9M 18M 27M Q3 '21: -4.3M Q4 '21: -9.5M Q1 '22: -5.1M Q2 '22: 1.6M Q3 '22: -1.1M Q4 '22: -5.7M Q1 '23: -13.1M Q2 '23: -7.3M Q3 '23: -23.7M Q4 '23: 18.2M Q1 '24: -4.5M Q2 '24: 6.6M Q3 '24: -20.7M Q4 '24: -13.3M Q1 '25: -6.1M Q2 '25: 551K Q3 '25: 10.3M Q4 '25: 7.7M Q1 '26: -1.4M Q2 '26: -682K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q3 '21: 1.6M Q4 '21: 1.3M Q1 '22: 889K Q2 '22: 1.1M Q3 '22: 1.2M Q4 '22: 1.2M Q1 '23: 1.3M Q2 '23: 1.2M Q3 '23: 1.4M Q4 '23: 2.2M Q1 '24: 1.6M Q2 '24: 1.9M Q3 '24: 2.3M Q4 '24: 2.3M Q1 '25: 2M Q2 '25: 2.2M Q3 '25: 2.5M Q4 '25: 3.4M Q1 '26: 2.2M Q2 '26: 2.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '21: -1.3M Q4 '21: 97K Q1 '22: -3.1M Q2 '22: -2.1M Q3 '22: -8M Q4 '22: -4M Q1 '23: -371K Q2 '23: -844K Q3 '23: -2M Q4 '23: -1.3M Q1 '24: 1.1M Q2 '24: -668K Q3 '24: 1.3M Q4 '24: 741K Q1 '25: -1.5M Q2 '25: 993K Q3 '25: 1.1M Q4 '25: 3.3M Q1 '26: 397K Q2 '26: 425K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '21: -3.4M Q2 '21: -2.1M Q3 '21: -1.4M Q4 '21: 9K Q1 '22: -3.1M Q2 '22: -2.1M Q3 '22: -8M Q1 '23: -389K Q2 '23: -995K Q3 '23: -2M Q1 '24: 986K Q2 '24: -760K Q3 '24: 1.2M Q4 '24: 505K Q1 '25: -1.7M Q2 '25: -166K Q3 '25: 556K Q4 '25: 3.2M Q1 '26: 374K Q2 '26: 91K Q2 '21 Q1 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 300M 600M 900M Q1 '20: 296.1M Q2 '20: 299.5M Q3 '20: 384.5M Q1 '21: 518.5M Q2 '21: 518.3M Q3 '21: 518.3M Q1 '22: 525.4M Q2 '22: 872M Q3 '22: 561.1M Q1 '23: 575M Q2 '23: 582.3M Q3 '23: 2.4M Q1 '24: 3.1M Q2 '24: 3.7M Q3 '24: 3.2M Q1 '25: 8.5M Q2 '25: 9.2M Q3 '25: 9.1M Q1 '26: 8.6M Q2 '26: 8.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.50 -7.00 -3.50 0.00 3.50 7.00 10.50 Q3 '20: -0.06 Q4 '20: -0.07 Q1 '21: -0.07 Q2 '21: -0.08 Q3 '21: -0.06 Q4 '21: -0.06 Q1 '22: -0.06 Q2 '22: -0.04 Q3 '22: -0.03 Q4 '22: -0.02 Q1 '23: -0.03 Q2 '23: -0.04 Q3 '23: -9.99 Q4 '24: -7.30 Q1 '25: -6.56 Q2 '25: -8.37 Q3 '25: -1.42 Q4 '25: 0.60 Q1 '26: 1.15 Q2 '26: 1.11 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.